References

  1. Slevin ML, Plant H, Lynch D, Drinkwater J, Gregory WM. Who should measure quality of life, the doctor or the patient? Br J Cancer 1988;57:109-112.
  2. Spilker B, Revicki DA. Taxonomy of quality of life. In: Spilker B, ed. Quality of Life and Pharmacoeconomics in Clinical Trials, 2nd ed. Philadelphia: Lippincott-Raven, 1996:25-31.
  3. McDowell I, Newell C. Measuring Health: A Guide to Rating Scales and Questionnaires. New York: Oxford University Press, 1987.
  4. Streiner,DL, Norman GR. Health Measurement Scales: A Practical Guide to Their Development and Use, 2nd ed. Oxford: Oxford Medical Publications, 1995.
  5. Brooks RG. Health Status Measurement: A Perspective on Change. Philadelphia: Macmillan, 1995.
  6. Spilker B, ed. Quality of Life and Pharmacoeconomics in Clinical Trials, 2nd ed. Philadelphia: Lippincott-Raven, 1996.
  7. Bergner M, Bobbitt RA, Carter WB, et al. The Sickness Impact Profile: development and final revision of a health status measure. Med Care 1981;19:787-805.
  8. Hunt SM, McEwen J, McKenna SP. Measuring health stats: a new tool for clinicians and epidemiologists. J Royal Coll Gen Pract 1985;35:185-188.
  9. Ware JE, Sherbourne CD. The MOS 36-item short form health survey (SF 36). I. Conceptual framework and item selection. Med Care 1992;30:473-483.
  10. EuroQoL Group. EuroQoL: a new facility for the measurement of health-related quality of life. Health Policy 1990;16:199-208.
  11. Mitchell JD, O'Brien MR. Quality of life in motor neurone disease—towards a more practical assessment tool? J Neurol Neurosurg Psychiatry. 2003;74:287-288.
  12. Schrag A, Selai C, Jahanshahi M, Quinn NP. The EQ-5D—a generic quality of life measure—is a useful instrument to measure quality of life in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 2000;69:67-73
  13. Peto V, Jenkinson C, Fitzpatrick R, Greenhall R. The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease. Qual Life Res 1995;4:241-248.
  14. de Boer AG, Wijker W, Speelman JD, de Haes JC . Quality of life in patients with Parkinson's disease: development of a questionnaire. J Neurol Neurosurg Psychiatry 1996;61:70-74.
  15. Marinus J, Ramaker C, van Hilten JJ, Stiggelbout AM. Health related quality of life in Parkinson's disease: a systematic review of disease specific instruments. J Neurol Neurosurg Psychiatry 2002;72:241-248.
  16. Peto V, Jenkinson C, Fitzpatrick R. PDQ-39: a review of the development, validation and application of a Parkinson's disease quality of life questionnaire and its associated measures. J Neurol 1998;245(Suppl 1):S10-S14.
  17. Schulzer M, Mak E, Calne SM. The psychometric properties of the Parkinson's Impact Scale (PIMS) as a measure of quality of life in Parkinson's disease. Parkinsonism Relat Disord 2003;9:291-294.
  18. Welsh M, McDermott MP, Holloway RG, Plumb S, Pfeiffer R, Hubble J, The Parkinson Study Group development and testing of the Parkinson's Disease Quality of Life Scale. Mov Disord 2003;18:637-645.
  19. Hogan T, Grimaldi R, Dingemanse J, Martin M, Lyons K, Koller W. The Parkinson's disease symptom inventory (PDSI): a comprehensive and sensitive instrument to measure disease symptoms and treatment side-effects. Parkin-sonism Relat Disord 1999;5:93-98.
  20. Van den Berg M. Leben mit Parkinson: Entwicklung und psychometrische Testung des Fragenbogens PLQ. Neurol Rehabil 1998;4:221-226.
  21. Marinus J, Visser M, Martinez-Martin P, van Hilten JJ, Stiggelbout AM. Questionnaire for patients with Parkinson's disease: the SCOPA-PS. J Clin Epidemiol 2003;56:61-67.
  22. Spliethoff-Kamminga NGA, Zwinderman AH, Springer MP, Roos RAC. Psychosocial problems in Parkinson's disease: evaluation of a disease-specific questionnaire. Mov Disord 2003;18: 503-509.
  23. Schrag A, Jahanshahi M, Quinn N. How does Parkinson's disease affect quality of life? A comparison with quality of life in the general population. Mov Disord 2000;15:1112-1118.
  24. Schrag A, Jahanshahi M, Quinn N.What contributes to quality of life in patients with Parkinson's disease? J Neurol Neurosurg Psychiatry 2000;69:308-312.
  25. Karlsen KH, Larsen JP, Tandberg E, Maland JG. Quality of life measurements in patients with Parkinson's disease: a community-based study. Eur J Neurol 1998;5:443-450.
  26. Kuopio AM, Marttila RJ, Helenius H, Toivonen M, Rinne UK. The quality of life in Parkinson's disease. Mov Disord 2000;15:216-223.
  27. Damiano AM, McGrath MM, Willian MK, et al. Evaluation of a measurement strategy for Parkinson's disease: assessing patient health-related quality of life. Qual Life Res 2000;9:87-100.
  28. Global Parkinson's Disease Survey Steering Committee. Factors impacting on quality of life in Parkinson's disease: results from an international survey. Mov Disord 2002;17:60-67.
  29. Litvan I, Mega MS, Cummings JL, Fairbanks L. Neuropsychiatric aspects of progressive supranuclear palsy. Neurology 1996;47:1184-1189.
  30. Aarsland D, Litvan I, Larsen JP. Neuropsychiatric symptoms of patients with progressive supranuclear palsy and Parkinson's disease. J Neuropsychiatry Clin Neurosci 2001;13:42-49.
  31. Fitzsimmons B, Bunting LK. Parkinson's disease—quality of life issues. Nurs Clin North Am 1993;28:807-818
  32. Fitzpatrick R, Peto V, Jenkinson C, Greenhall R, Hyman N. Health-related quality of life in Parkinson's disease: a study of outpatient clinic attenders. Mov Disord 1997;12:916-922.
  33. Nath U, Ben-Shlomo Y, Thomson RG, Lees AJ, Burn DJ. Clinical features and natural history of progressive supranuclear palsy: a clinical cohort study. Neurology 2003;60:910-916.
  34. Schrag A, Selai D, Davis J, Lees A, Jahanshahi M, Quinn N. Health-related quality of life in patients with progressive supranuclear palsy (PSP). Mov Disord 2003;18:1464-1469.
  35. Uttl B, Santacruz P, Litvan I, Grafman J. Caregiving in progressive supranuclear palsy. Neurology 1998;51:1303-1309.

Was this article helpful?

0 0

Post a comment